A BEAUTY and cosmetics company said it is willing to pull out some of its products from the market but clarified that it had nothing to do with their quality, rather with their registration that has been pending before the Food and Drug Administration (FDA).
In a statement, John Eric Ho, the corporate communications head of the Belo Medical Group (BMG), said that the firm shared the FDA objective to protect public health by making certain all drugs sold to them are safe and appropriately registered.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.